ARA-290 (Cibinetide) is a breakthrough peptide derived from the structure of erythropoietin (EPO), specifically engineered to target the Innate Repair Receptor (IRR).
As a potent anti-inflammatory and neuroprotective agent, ARA-290 is primarily studied for its ability to:
-
Combat Small Fiber Neuropathy (SFN): Research indicates it may help alleviate neuropathic pain by reducing pro-inflammatory cytokines and promoting nerve fiber density.
-
Modulate the Immune Response: It works by “switching off” the inflammatory gold-standard response in damaged tissues without affecting healthy systemic functions.
-
Enhance Metabolic Health: Studies have explored its role in improving glucose metabolism and protecting against tissue ischemia.
For a full scientific overview of ARA290, see our research reference page:
ARA290 — Overview
Bulk orders automatically save 20% on any 10+ vials (BAC excluded)
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.